BB Good human data, but mixed outcomes or surrogate markers. How we grade →Randomized controlled trial · 409 adults with newly diagnosed type 2 diabetes, 20 centres
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
Y Zhang, Y Gu, H Ren, et al. Nature Communications. 2020.
Bottom line: In 409 Chinese adults with newly diagnosed type 2 diabetes, 12 weeks of berberine lowered HbA1c more than placebo; probiotics alone did not add benefit.
- In plain language
- This randomized, double-blind, placebo-controlled trial enrolled 409 adults with newly diagnosed type 2 diabetes at 20 centres in China. After a one-week run-in with the antibiotic gentamicin, participants took berberine (600 mg twice a day), probiotics plus berberine, probiotics alone, or placebo for 12 weeks. HbA1c fell by 0.99 percentage points with berberine and 1.04 with probiotics plus berberine, significantly more than with placebo (0.59) or probiotics alone (0.53). Berberine caused more digestive side effects.
- Limits
- All participants took the antibiotic gentamicin for a week first, which may not reflect normal use; the trial lasted only 12 weeks and was done only in China. Northeast Pharmaceutical Group supplied berberine and placebo but had no role in design or analysis.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Berberine and glucose metabolism
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →Graded claim: Berberine HCl: Lower blood sugar in adults with high blood sugar or type 2 diabetes (the people trials studied)
- CC Small or few human trials. Promising, not proven. How we grade →Ratings card: Berberine HCl: Healthy glucose metabolism
- Source
- doi.org/10.1038/s41467-020-18414-8 · PubMed 33024120 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. Reviewed . We sell some of what we grade.